Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06410976 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Clinical Assessment Study in Children With Hypochondroplasia

Study acronym: HCH
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Secondary endpoints: details revised at 1 of 5 entries
    • Study sites revised (25)
    v17
  2. Minor Secondary endpoints: details revised at 5 of 5 entries
    • Site details revised at 2 of 25 sites
    • Eligibility criteria expanded, about 2 words
    v16
  3. Minor Site details revised at 1 of 25 sitesv15
  4. Minor Site details revised at 1 of 25 sitesv14
  5. Minor Study sites revised (25)v13
Show 11 earlier versionsHide 11 earlier versions
  1. Minor Study sites revised (25)v12
  2. Minor Site details revised at 6 of 25 sitesv11
  3. Minor Site details revised at 2 of 25 sitesv10
  4. Minor Site details revised at 2 of 25 sitesv9
  5. Minor Study sites: 26 to 25v8
  6. Minor Site details revised at 4 of 26 sitesv7
  7. Minor Site details revised at 1 of 26 sitesv6
  8. Minor Study sites revised (26)v5
  9. Minor Site details revised at 1 of 26 sitesv4
  10. Minor Study sites: 13 to 26
    • Start date changed from estimate of May 2024 to Jun 5, 2024
    v3
  11. Notable Primary endpoint revised
    • Secondary endpoints revised (5)
    • Study description expanded, about 42 words
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a long-term, multicenter, non-interventional study of children ages 2.5 to \<17 years with hypochondroplasia (HCH).
Trial Details
NCT Number NCT06410976
Lead Sponsor QED Therapeutics, a BridgeBio company
Conditions
(from sponsor)
Hypochondroplasia
Related terms Bone Diseases, Dwarfism, Genetic Diseases, Inborn, Hypochondroplasia, Mucopolysaccharidosis IV, Musculoskeletal Diseases, Osteochondrodysplasias
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov